Literature DB >> 7637495

New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains.

M Ristow, M Möhlig, M Rifai, H Schatz, K Feldmann, A Pfeiffer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7637495     DOI： 10.1016/s0140-6736(95)91351-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  A balancing act: efflux/influx in mycobacterial drug resistance.

Authors:  G E Louw; R M Warren; N C Gey van Pittius; C R E McEvoy; P D Van Helden; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

2.  Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level.

Authors:  A Telenti; N Honoré; C Bernasconi; J March; A Ortega; B Heym; H E Takiff; S T Cole
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients.

Authors:  H J Marttila; H Soini; P Huovinen; M K Viljanen
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

4.  Deficiency of phosphofructo-1-kinase/muscle subtype in humans impairs insulin secretion and causes insulin resistance.

Authors:  M Ristow; M Vorgerd; M Möhlig; H Schatz; A Pfeiffer
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

5.  Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis.

Authors:  C Vilchèze; H R Morbidoni; T R Weisbrod; H Iwamoto; M Kuo; J C Sacchettini; W R Jacobs
Journal:  J Bacteriol       Date:  2000-07       Impact factor: 3.490

6.  The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg-->Leu mutation at codon 463 of katG are not associated.

Authors:  H R van Doorn; E J Kuijper; A van der Ende; A G Welten; D van Soolingen; P E de Haas; J Dankert
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

7.  ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates.

Authors:  Glenn P Morlock; Beverly Metchock; David Sikes; Jack T Crawford; Robert C Cooksey
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

8.  Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3'-minor groove binder-DNA probes.

Authors:  H Rogier van Doorn; Eric C J Claas; Kate E Templeton; Adri G M van der Zanden; Arianne te Koppele Vije; Menno D de Jong; Jacob Dankert; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

9.  In vitro inhibition of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA by isoniazid.

Authors:  Stéphanie Ducasse-Cabanot; Martin Cohen-Gonsaud; Hedia Marrakchi; Michel Nguyen; Didier Zerbib; Jean Bernadou; Mamadou Daffé; Gilles Labesse; Annaïk Quémard
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.